Omeprazole in the management of sclerotherapy-induced esophageal ulcers resistant to H2 blocker treatment.
Jaspersen
D
D
Department of Medicine, Academic Medical Hospital, Fulda, Germany.
Körner
T
T
Schorr
W
W
Hammar
C H
CH
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004351:Drug Resistance; D004935:Esophageal Diseases / Q000188:drug therapy* / Q000209:etiology; D004932:Esophageal and Gastric Varices / Q000628:therapy; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use*; D011899:Ranitidine / Q000627:therapeutic use*; D015911:Sclerotherapy / Q000009:adverse effects*; D014456:Ulcer / Q000188:drug therapy / Q000209:etiology
D011899:Ranitidine; D009853:Omeprazole